Kelley's Optical & Boutique

07/18/2026

07/14/2026

LONDON and WARREN, N.J.,—Tenpoint Therapeutics, Ltd., a global commercial-stage ophthalmic pharmaceutical company focused on developing treatments to improve vision in the aging eye, has submitted a marketing authorization application (MAA) to the United Kingdom’s Medicines and Healthcare products Regulatory Agency (MHRA) for the review and approval of Yuvezzi (carbachol and brimonidine tartrate ophthalmic solution) 2.75%/0.1%, a once- daily, dual-agent (combination) eye drop for the treatment of presbyopia in adults, according to an announcement from the company.

LONDON and WARREN, N.J.,—Tenpoint Therapeutics, Ltd., a global commercial-stage ophthalmic pharmaceutical company focused on developing treatments to improve vision in the aging eye, has submitted a marketing authorization application (MAA) to the United Kingdom’s Medicines and Healthcare produc...

06/29/2026

CHICAGO—Prevent Blindness, a nonprofit eye health organization, has declared July as Dry Eye Month to raise awareness and educate the public and health care allies about dry eye. The condition occurs when tears do not provide adequate lubrication for the eyes and in some cases can decrease vision. If left untreated, the condition may cause damage to the front of the eye. Prevent Blindness is offering free dry eye resources, including a dedicated webpage, fact sheets and social media graphics, available in English and Spanish, as well as videos from experts and patients.

CHICAGO—Prevent Blindness, a nonprofit eye health organization, has declared July as Dry Eye Month to raise awareness and educate the public and health care allies about dry eye. The condition occurs when tears do not provide adequate lubrication for the eyes and in some cases can decrease vision....

06/24/2026

WATERLOO, Ontario—The Centre for Ocular Research and Education (CORE) has dedicated Issue 90 of Contact Lens Update to the topic of artificial intelligence (AI), focusing on the challenges, opportunities and paths forward. The bi-monthly publication is available at no charge by visiting ContactLensUpdate.com. AI has the potential to rapidly transform myopia management, offering new capabilities for predicting progression, personalizing treatment and improving clinical decision-making, CORE said in an announcement. “AI is not a substitute for clinicians, but it can augment their clinical reasoning,” said Daddi Fadel, adjunct assistant professor at the University of Waterloo and a consultant for CORE.
http://www.visionmonday.com/eyecare/eye-health/article/latest-core-publication-explores-ais-role-in-myopia-management/

WATERLOO, Ontario—The Centre for Ocular Research and Education (CORE) has dedicated Issue 90 of Contact Lens Update to the topic of artificial intelligence (AI), focusing on the challenges, opportunities and paths forward. The bi-monthly publication is available at no charge by visiting ContactLen...

06/19/2026

COLUMBIA, Md.—The Foundation Fighting Blindness, a private funding source for retinal degenerative disease research and its venture arm, the RD Fund (Retinal Degeneration Fund), have announced a $1 million commitment from A Race Against Blindness (RAB) to advance gene-agnostic therapeutic approaches for inherited retinal diseases. The commitment includes $775,000 for the RD Fund and $225,000 for a Foundation Fighting Blindness research award. The $775,000 contribution to the RD Fund will be matched dollar for dollar through the Gordon and Llura Gund Foundation Challenge, unlocking a total of $1.55 million in funding. The challenge doubles all new and increased gifts to the RD Fund, according to the announcement.

COLUMBIA, Md.—The Foundation Fighting Blindness, a private funding source for retinal degenerative disease research and its venture arm, the RD Fund (Retinal Degeneration Fund), have announced a $1 million commitment from A Race Against Blindness (RAB) to advance gene-agnostic therapeutic approach...

06/05/2026

CAMBRIDGE, Mass.—Luminopia Inc., a digital health company pioneering a new class of treatments for neuro-visual disorders, announced its first international licensing agreement with ROHTO Pharmaceutical Co. Ltd., a Japanese multinational corporation specializing in consumer products and pharmaceuticals, with a primary focus on eyecare. The agreement grants ROHTO exclusive rights to develop and commercialize Luminopia’s digital therapy for pediatric amblyopia in the Japanese market.

CAMBRIDGE, Mass.—Luminopia Inc., a digital health company pioneering a new class of treatments for neuro-visual disorders, announced its first international licensing agreement with ROHTO Pharmaceutical Co. Ltd., a Japanese multinational corporation specializing in consumer products and pharmaceut...

06/05/2026

NEWARK, N.J.—The readers of Vision Monday and 20/20 magazine are being asked once again to share nominations for their Ultimate Partners, but time is running out—the deadline for submissions is today, June 5, at 11:59 pm ET. Now in its sixth year, Jobson’s 2026 Ultimate Partners program allows readers to highlight their great business support partners and showcase their assistance. Open to all eyecare professionals, the program is looking to spotlight your most successful collaborations and celebrate the crucial support shared during both challenges and opportunities. Our ever-changing workplace renders partnership more vital than ever, and we want to hear your teamwork success stories.

NEWARK, N.J.—The readers of Vision Monday and 20/20 magazine are being asked once again to share nominations for their Ultimate Partners, but time is running out—the deadline for submissions is today, June 5, at 11:59 pm ET. Now in its sixth year, Jobson’s 2026 Ultimate Partners program allows...

06/03/2026

NEWARK, N.J.—The readers of Vision Monday and 20/20 magazine are being asked once again to share nominations for their Ultimate Partners, but time is running out—the deadline for submissions is Friday, June 5. Now in its sixth year, Jobson’s 2026 Ultimate Partners program allows readers to highlight their great business support partners and showcase their assistance. Open to all eyecare professionals, the program is looking to spotlight your most successful collaborations and celebrate the crucial support shared during both challenges and opportunities. Our ever-changing workplace renders partnership more vital than ever, and we want to hear your teamwork success stories.

NEWARK, N.J.—The readers of Vision Monday and 20/20 magazine are being asked once again to share nominations for their Ultimate Partners, but time is running out—the deadline for submissions is Friday, June 5. Now in its sixth year, Jobson’s 2026 Ultimate Partners program allows readers to hig...

06/02/2026

MIAMI—The University of Miami School of Medicine has announced the appointment of Pradeep Y. Ramulu, MD, MHS, Ph.D., as chair of the department of ophthalmology and the Bascom Palmer Eye Institute, effective August 3, 2026. Dr. Ramulu is a Bascom Palmer alumnus who “returns to lead the institution where his career in glaucoma was shaped, bringing with him nearly two decades of transformative clinical, research and educational leadership from the Wilmer Eye Institute at Johns Hopkins University,” the Institute said in an announcement. As chair, Dr. Ramulu will hold the Kathleen and Stanley J. Glaser chair in ophthalmology.

MIAMI—The University of Miami School of Medicine has announced the appointment of Pradeep Y. Ramulu, MD, MHS, Ph.D., as chair of the department of ophthalmology and the Bascom Palmer Eye Institute, effective August 3, 2026. Dr. Ramulu is a Bascom Palmer alumnus who “returns to lead the instituti...